COVID-19 vaccine hope dampens prospects for stay-at-home darlings

Platform News: Video streaming services and VOD

The surge in stocks of Netflix , Zoom and other of this year’s stay-at-home company winners has been brought to a sudden halt by promising vaccine data suggesting a possible way out of the COVID-19 pandemic.

The jury was still out on Tuesday, but as to whether that reverse, sparked by positive information from trials run by US drugs giant Pfizer and Germany’s BioNtec, could last.

Shares in video conferencing network Zoom dropped 4 percent on Tuesday after plunging about 17 percent every day earlier. But both exercise bike maker Peloton, that sank more than 20 percent on Monday, and Netflix, really gained ground on Tuesday.

Tech heavyweights from Alphabet to Apple and Amazon also endured but have mushroomed hugely in value this season.

“Even if a vaccine proves effective, inoculating a large enough part of the population will take time and leave these segments prone to economic lockdown fallout,” said Commerzbank analyst Christoph Rieger.

The shakiness of motions may have reflected both doubts regarding the rate in which a vaccine can be produced and distributed in addition to the remaining doubts about whether it will function as a remedy in the long-run.

Related Article:
Zynga to buy mobile ad focused Chartboost, raises bookings forecast

However, there’s also the conviction that the pandemic has basically changed business for a number of these businesses in a way which will not be reversed.

Peloton, that has seen demand for its at-home physical fitness programs soar due to fitness centre closures, recently posted a 274% leap in annual profit for its own unit that sells interactive exercise equipment.

An outstanding beneficiary among tech stocks from the change to work from home is Zoom, whose stocks have jumped over 460% annually as corporate companies, schools, and associations run innumerable digital meetings on its video conferencing app. and Microsoft have observed a significant boost to their business but the capital they have available for new investment has soared as a consequence – potentially giving them more leverage moving forward.

Shares of video game and e-sports associated businesses, which gained from extended cancellations of standard sports leagues, tumbled after Pfizer’s announcement, even with game studios such as Activision Blizzard and Take-Two Interactive Software ending Monday’s session reduced.

Gaming peripheral makers like Turtle Beach and Corsair Gaming also tumbled on Monday, while US listed shares of game developers and e-sports organizers Bilibili Inc and Sea Limited watched their worst day since March.

Related Article:
Samsung to invest $206 billion by 2023 for post-pandemic growth

All, however, are up between 50% and 350% since March, while Corsair has climbed 57% since its first public offering in September.

“The market is likely discounting a deceleration of growth for the sector in 2021,” said Will Hershey, CEO of Roundhill Investments.

“However, I believe that the growth in gaming due to the pandemic likely increased the trajectory of gaming adoption for years to come.”

The team at Platform Executive hope you have enjoyed the ‘COVID-19 vaccine hope dampens prospects for stay-at-home darlings‘ article. Initial reporting via our official content partners at Thomson Reuters. Reporting by Noor Zainab Hussain, Sanjana Shivdas, Shreyashi Sanyal, Munsif Vengattil and Medha Singh and Lisa Pauline Mattackal in Bengaluru. Editing by Patrick Graham.

Stay on top of the latest developments across the platform economy and gain access to our problem-solving tools, proprietary databases and content sets by becoming a premium member. Subscription plans start at under $7 per month.

Share this Article